Forward P/S Multiple: EDAP TMS SA (EDAP)
French business EDAP TMS S.A. (EDAP) relies on its leadership in non-invasive cancer treatment while facing risks of disruptions in Asian electronics supplies. Stability is provided by a loyal staff of engineers and trainers, which confirms the future significance of the P/S multiple. This chart helps distinguish a temporary markdown from a crisis, and 2.20 captures the current state of the parameter.
Summary analytical data breakdowns for edap-tms.com (EDAP)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
EDAP - Company Net Income|Expected Profit EDAP TMS S.A.|EDAP - Market Cap to Net Income Ratio|Projected Price to Earnings EDAP TMS|EDAP - PEG Multiple|EV/EBITDA Multiple EDAP|EDAP - Operating income before deduction of amortization|Earnings per share for the last twelve months EDAP TMS|EDAP - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months edap-tms.com|EDAP - Net earnings per share growth this year|Earnings growth forecast for next year EDAP TMS S.A.
- sales and revenue indicators:
Fundamental company analysis:EDAP (EDAP Medical)
The status of a medical equipment manufacturer with low geopolitical risk provides EDAP TMS S.A. (EDAP) stable access to global healthcare markets. By analyzing the forward price-to-sales valuation, an investor compares current market capitalization with projected sales, which helps identify whether the asset is overbought or possesses growth potential through the dynamics of market expectations captured on this chart.
Who EDAP TMS S.A. competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Market Cap to Future Revenue Ratio profusa.com (PFSA)|SSKN (STRATA Skin Sciences Inc.) - Forward P/S Multiple|Market Cap to Projected Revenue GCTK (glucotrack.com)|Forward P/S Multiple NAOV|Forward P/S Multiple Venus Concept Corporation (VERO)|Price-to-Projected Revenue Ratio Nuwellis, Inc. NUWE|AEMD (aethlonmedical.com) - Future Price to Revenue|ASXC: Forward Price-to-Revenue Multiple|Forward Price to Sales AVGR (Avinger Inc.)|BSGM (BioSig Technologies, Inc) - Forward Price-to-Revenue Multiple|CUTR: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Know Labs, Inc.|Forward Price-to-Revenue Multiple inarimedical.com (NARI)|Price-to-Projected Revenue Ratio Nevro (NVRO)|Market Cap to Expected Sales Ratio reshapelifesciences.com|Silk Road Medical Inc. - Forward Price-to-Revenue Multiple
